🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase II trial studies how well nivolumab or expectant obse...
Status
Withdrawn
Location
Alliance for Clinical Trials in Oncology
Start Date
2017-11-03
Trial ID
NCT03220009
To compare the efficacy of nivolumab plus ipilimumab in subjects with high ...
Status
Unknown
Location
University of Heidelberg
Start Date
2019-12-12
Trial ID
NCT04131621
Treatments Being Tested
The purpose of this study is to evaluate real-world effectiveness of neoadj...
Status
Completed
Location
Centre François Baclesse
Start Date
2024-09-05
Trial ID
NCT06735781
Treatments Being Tested
Addition of nivolumab (immune checkpoint inhibitor) to standard chemotherap...
Status
Enrolling By Invitation
Location
Dmitry Rogachev National Research Center
Start Date
2024-09-01
Trial ID
NCT06871007
Treatments Being Tested
This is a multi-center, open-label phase IIA study that investigates the pr...
Status
Recruiting
Location
University of California, Irvine
Start Date
2017-07-01
Trial ID
NCT03259867
Treatments Being Tested
Patients with malignant pleural mesothelioma stage I-III who have undergone...
Status
Completed
Location
Vivantes Klinikum Neukölln, Klinik für Hämatologie, Onkologie und Palliativmedizin
Start Date
2019-02-04
Trial ID
NCT04177953
Treatments Being Tested
To assess the clinical activity of nivolumab monotherapy, as measured by th...
Status
Withdrawn
Location
Hospital Beatriz Ângelo
Start Date
2018-10-01
Trial ID
NCT03726281
Treatments Being Tested
The purpose of this study is to understand the characteristics of adults di...
Status
Completed
Location
Cardinal Health
Start Date
2025-05-11
Trial ID
NCT07091695
Treatments Being Tested
This was an observational study utilizing electronic health record (EHR)-de...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-06-16
Trial ID
NCT05611229
Immune checkpoint inhibitors (ICIs) might induce high grade immune-related ...
Status
Unknown
Location
AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM.
Start Date
2019-01-01
Trial ID
NCT04294771
Treatments Being Tested